Overview

A Study of Iron Oligosaccharide in CHF Patients

Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety profile of iron oligosaccharide in patients with congestive heart failure with a need for parenteral iron.
Phase:
Phase 3
Details
Lead Sponsor:
Pharmacosmos A/S
Treatments:
Iron